Personen

TOP 5 Publikationen:

1. Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Eisenacher S, Thiem J, Meyer-Lindenberg A, Zink M. Response to Agomelatine Treatment is Independent of Smoking Status and Dosage: Results From the AGOPSYCH Study.Pharmacopsychiatry. 2019 52(3):142-146. Epub 2018 May 7.
2. Englisch S, Jung HS, Eisenacher S, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Meyer-Lindenberg A, Zink M. Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study.J Clin Psychopharmacol. 2018 38(4):357-361.
3. Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Eisenacher S, Meyer-Lindenberg A, Zink M. Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study.J Clin Psychopharmacol. 2016 36(6):597-607. Epub 2016 Oct 29.